Innovata Biomed (IB), the respiratory division of ML Laboratories (ML) and Pliva dd (Pliva), a rapidly growing multinational pharmaceutical company, announce that they have entered into an agreement to develop a novel asthma medication based on Pliva's novel steroid PLD-177 and IB’s multi-dose breath-actuated dry powder inhaler Clickhaler.